Home
Conditions
Myelodysplastic Syndromes

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

268 public trials 58 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Recruiting

Long-term Safety and Tolerability of MY008211A Tablets in Patients With Paroxysmal Nocturnal Hemoglobinuria

NCT06933914

Conditions: Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations: Chinese Academy of Medical Sciences Hematology Hospital (Institute of Hematology, Chinese Academy of Medical Sciences) Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Anti-NKG2A Monoclonal Antibody for AML or MDS Patients Undergoing Haploidentical Transplantation

NCT06892223

Conditions: Acute Myeloid Leukaemia, Anemia, Anemia, Refractory, +13 more
Locations: IRCCS Ospedale Policlinico San Martino Genova, GENOVA, Italy

Irccs Istituto Clinico Humanitas Rozzano, MILANO, Italy

View Trial Details

Recruiting

Global PNH Patient Registry

NCT05755867

Conditions: Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations: Aplastic Anemia and MDS International Foundation Bethesda, Maryland, United States

View Trial Details

Recruiting

Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors

NCT06785077

Conditions: Adnexal Diseases, Anemia, Anemia, Refractory, +28 more
Locations: Istituto Europeo di Oncologia Milan, Italy

View Trial Details

Recruiting

Long-term Safety and Tolerability of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria

NCT06745622

Conditions: Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations: The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Recruiting

Repurposing Metformin As a Leukemia-preventive Drug in CCUS and LR-MDS

NCT04741945

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +10 more
Locations: Rigshospitalet Copenhagen, Copenhagen N, Denmark

View Trial Details

Recruiting

Intensive Conditioning withTHI/Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary Involvement

NCT06111612

Conditions: Acute Myeloid Leukemia, Anemia, Anemia, Refractory, +23 more
Locations: Shanghai General Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs)

NCT06213402

Conditions: Anemia, Anemia Due to Membrane Defect, Anemia, Hemolytic, +29 more
Locations: Vall d'hebron Research Institute - Vall d'Hebron Research Institute - University Hospital Vall d'Hebrón (VHIR/HUVH) Barcelona, Catalonia, Spain

View Trial Details

Enrolling by Invitation

A Multicenter, Open-label Study Evaluating the Long-term Safety and Efficacy of XH-S003 Capsules in Patients With Paroxysmal Nocturnal Hemoglobinuria

NCT07657052

Conditions: Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations: TianJin Medical University General Hospital Tianjin, Jinan, China

View Trial Details

Not Yet Recruiting

PRAISE-IR Versus CIBMTR Controls

NCT07717164

Conditions: ALL (Acute B-Lymphoblastic Leukemia), AML (Acute Myeloid Leukemia), Anemia, +12 more
Locations: Memorial Sloan Kettering Cancer center New York, United States

View Trial Details

Myelodysplastic Syndromes

Myelodysplastic Syndromes trial results

Related conditions